Background: The cut-o® values of walking velocity and classi¯cation of functional mobility both have a role in clinical settings for assessing the walking function of stroke patients and setting rehabilitation goals and treatment plans. Objective: The present study investigated whether the cut-o® values of the modi¯ed Rivermead Mobility Index (mRMI) and walking velocity accurately di®erentiated the walking ability of stroke patients according to the modi¯ed Functional Ambulation Category (mFAC). Methods: Eighty two chronic stroke patients were included in the study. The comfortable/maximum walking velocities and mRMI were used to measure the mobility outcomes of these patients. To compare the walking velocities and mRMI scores for each mFAC point, one-way analysis of variance and the post-hoc test using Sche®e's method were performed. The patients were categorized according to gait ability into either mFAC ¼ VII or mFAC VI group. The cut-o® values for mRMI and walking velocities were calculated using a receiver-operating characteristic curve. The odds ratios of logistic regression analysis (Wald Forward) were analyzed to examine whether the cut-o® values of walking velocity and mRMI can be utilized to di®erentiate functional walking levels. Results: Except for mFACs III and IV, maximum walking velocity di®ered between mFAC IV and mFAC V (p < 0:01), between mFAC V and mFAC VI (p < 0:001), and between mFAC VI and mFAC VII (p < 0:05).
Introduction
The walking function of stroke patients is closely related to mobility, walking velocity, cardiovascular endurance, dynamic balance, motor skill, and muscular strength in the lower limb of the a®ected side. 1, 2 Recovery of functional mobility and walking function is the priority of rehabilitation after stroke. 3 Therefore, in clinical settings physical therapists assess the gait and mobility of stroke patients using standardized assessments such as walking velocity 4 and the modi¯ed Rivermead Mobility Index (mRMI). 5 The modi¯ed Functional Ambulation Category (mFAC), which uses a seven-point Likert scale, is a tool for clinical assessment of walking ability in stroke patients that uses a Functional Ambulation Classi¯cation system. The mFAC has been shown to have a high correlation (r ¼ 0:88-0.90) with walking velocities (comfortable/maximum) and mRMI performance scores. 6 In other words, as the functional gait ability is recovered in stroke patients, the physical measurements of walking velocity and mRMI are increased. In one correlation study, 6 there were signi¯cant di®erences in walking velocity and mRMI scores, as re°ected by the mFAC scores between stroke patients (from III to V points) and the independent ambulatory group (VI and VII points). Tsang et al. 7 found signi¯cant di®erences in average walking velocity between di®erent mFAC scores (III-VII) of 62 stroke patients, and they determined that mFAC could accurately classify the ambulation levels. However, results from these studies focused on only the statistical di®erences in mRMI and walking velocities in stroke patients. It is not clear whether the mFAC score may be determined based only on values of mRMI and walking velocities.
Previous studies proposed the cut-o® values of walking velocities for community ambulation.
Three levels of community ambulation have been classi¯ed with the following thresholds: most limited community walkers (25 m/min), limited community walkers (35 m/min), and community walkers (48 m/min). 8 Previous literature determined cut-o® values of community ambulation levels according to the walking velocity (indoor ambulation: > 0:4 m/s, limited community ambulation: 0.4-0.8 m/s, and community ambulation: > 0:8 m/s). 9 The cut-o® values of walking velocity and classi¯cation of functional mobility both have a role in clinical settings for assessing the walking function of stroke patients and setting rehabilitation goals and treatment plans.
The aim of this study was to quantitatively categorize two di®erent mFAC groups using cut-o® values of walking velocity and mRMI. This study investigated whether the cut-o® values of walking velocity and mRMI can be discriminatory measures of functional ambulation for stroke patients categorized into two groups, mFAC ¼ VII and mFAC VI. In this study, we used the de¯nitions of discrimination suggested in previous literature. 10 Lord et al. 10 stated that when the community-walking ability was classi¯ed into four levels, the walking velocity increased as the level of gait ability increased, and the walking velocity decreased as the level of gait ability decreased. As a result, walking velocity was deemed to be a suitable measurement for discriminating the four levels of community walking categorized by a self-questionnaire. The hypotheses of this study are as follows: (1) there will be signi¯cant di®erences in walking velocities and mRMI in di®erent mFAC categories, (2) there will be signi¯cant di®erences in walking velocities and mRMI between the two groups, and (3) the cut-o® values of walking velocity and mRMI will be discriminatory indicators for mFAC.
Methods

Participants
This study was a cross-sectional investigation conducted with 91 patients with chronic hemi-paralysis caused by stroke. Our participants consisted of both inpatients and outpatients at M hospital. The study design was blinded for assessment and intention-to-treat analysis. Participants had cognitive function scoring of no less than 23 points on the Mini-Mental State Examination-Korean version (MMSE-K). 11 The participants did not have a lower motor neuron lesion or an orthopedic disease in the lower limbs. Ninety one chronic stroke patients initially enrolled on the basis of these inclusion criteria. General characteristics collected via hospital records and interviews included age, time since onset, diagnosis, location of paralysis, and MMSE-K scores. The procedures of this study were approved by Konyang University Institutional Review Board (IRB Approval No. 2017-066) and the participants signed the informed consent form prior to study participation.
Assessment procedures
Outcome assessment was performed by two physical therapists with more than 15 years of experience (SH, DS) in stroke treatment and diverse evaluation methods including the study's evaluation methods. The assessments were completed within 30 min, and the investigators provided a break for all participants between the two assessments to minimize the e®ect of fatigue.
Measures
The outcome measures in this study were composed of two standardized mobility assessments including the mFAC and a seven-point scale for classifying the gait ability of participants. The mobility measures were: (1) comfortable walking velocity (CWV, m/s) and maximum walking velocity (MWV, m/s), as measured by the modi¯ed 5-m Ambulation Velocity Test, which includes a 2-m acceleration and deceleration interval, for a total distance of 9 m, which helped minimize the necessary space and lessened the mental burden and stress of participants. 12 All subjects were asked to stop at the marked end point, and were instructed to walk as fast as they could three times while maintaining the safety. The examiner recorded the time taken to walk from the end of the 2-m acceleration mark to the start of the 2-m deceleration mark. (2) The mRMI score is determined based on eight questions about mobility. The interrater reliability of mRMI [intra-class correlation co-e±cient ðICCÞ ¼ 0:98] 5 and test-retest reliability (ICC ¼ 0:99) have been established in stroke patients. 7 To determine each participant's ambulation ability, the primary physical therapist (SH) evaluated the mFAC 13 with the following criteria. Depending on the need for physical assistance, ambulation ability was scored as I point (unable to perform ambulation but able to maintain sitting position for 1 min with assistance, or unable to keep the position for 1 min without hand or back support); II points (unable to perform ambulation but able to maintain sitting position for 1 min without supporting self with hands or back support); III points (need someone to provide constant and reliable assistance for ambulation); IV points (need someone to provide constant or intermittent assistance for ambulation); V points (need verbal cues and supervision for ambulation); VI points (able to perform indoor ambulation on level ground); and VII points (able to perform outdoor ambulation). The mFAC test-retest reliability (concordance rate ¼ 93%, weighted kappa coefficient ¼ 0:97) was reported in stroke patients. 7 The participants were assigned to groups according to walking levels using the mFAC. The mFAC is a seven-point scale that classi¯es the walking function level. In the current study, functional gait ability (i.e., outdoor gait ability) was de¯ned depending on whether a patient could perform activities such as climbing the stairs, walking on uneven levels, etc.; the e®ect of this ability on social outcomes was not considered. If the participants could perform outdoor ambulation, they were categorized into an mFAC ¼ VII group (high-level ambulation group, HG). If the tasks could not be performed, the categorization was mFAC VI (low-level ambulation group, LG). In this study, the participants' functional walking levels were separated into two groups with mFAC ¼ VII points (HG) and VI points (LG). 14 All the participants were unaware of their classi¯cation.
Statistical analysis
Descriptive statistics were computed for data, including the data regarding general characteristics, mFAC points, mRMI score, and comfortable and maximum walking velocities. For comparing the walking velocities and mRMI scores for each mFAC point, we used one-way analysis of variance and performed the post-hoc test using Sche®e's method. The Mann-Whitney test was conducted to compare the walking velocities and mRMI scores of HG and LG. For the comparative analysis of e®ect size, Cohen d was utilized. The cut-o® value was produced by using the receiver-operating characteristic curve (ROC curve) for the di®erentiation of walking velocity and mRMI for functional walking levels. In the area under the ROC curve (AUC), 0:5 < AUC 0:7 indicates lower precision, 0:7 < AUC 0:9 indicates mid-level precision, 0:9 < AUC < 1:0 indicates high precision, and AUC ¼ 1:0 indicates complete test. 15 With respect to the cut-o® values of walking velocity and mRMI, the odds ratio (OR) in logistic regression analysis (Wald Forward) was used to estimate the discriminative validity of functional walking levels. All data were analyzed using IBM SPSS Statistics version 20.0 (IBM Corp., Armonk, NY, USA) and the statistical signi¯cance level was set at ¼ 0:05.
Results
Subjects' characteristics
Six participants dropped out during the examination period due to a deteriorating health condition or discharge from the hospital. Ultimately, 82 participants were included in the study analysis. The general characteristics of the participants are provided in Table 1 . The participants were within the mFAC range of III-VII.
Walking velocity and mRMI in di®erent mFAC categories
The walking velocities and mRMI scores of 82 chronic patients of mFAC categories III-VII were measured (see Table 2 ). The mean CWV increased from 0. (SD ¼ 0:12) for mFAC V, 0.88 m/s (SD ¼ 0:11) for mFAC VI, and 1.20 m/s (SD ¼ 0:21) for mFAC VII. There were signi¯cant di®erences in both velocities between patients of mFAC IV and those of mFAC V (p < 0:01), between patients of mFAC V and those of mFAC VI (p < 0:001), and between patients of mFAC VI and those of mFAC VII (p < 0:05). The mean mRMI score increased from 17.0 (SD ¼ 3:68) for mFAC III to 20.54 (SD ¼ 2:66) for mFAC IV, 27.56 (SD ¼ 3:65) for mFAC V, 28.55 (SD ¼ 3:31) for mFAC VI, and 32.33 (SD ¼ 3:74) for mFAC VII. There were statistically signi¯cant di®erences in the mRMI scores between patients of mFAC IV and mFAC V (p < 0:001) and between those of mFAC VI and mFAC VII (p < 0:05).
Comparison of mobility outcomes between groups
The results of the mRMI performance score and comfortable and maximum velocities are shown in Table 3 . Between the HG and LG groups, there were signi¯cant di®erences in mRMI scores, CWVs, and MWVs (all p < 0:001).
Cut-o® value, AUC, sensitivity, and speci¯city
The mRMI cut-o® value, sensitivity, and speci¯city were > 26:5 scores, 95%, and 62%, respectively. The CWV cut-o® value, sensitivity, and speci¯city for functional walking distinction were > 0:77 m/s, 90%, and 88%, respectively. The MWV cut-o® value, sensitivity, and speci¯city were > 0:92 m/s, 85%, and 93%, respectively (Table 4 ). With regression coe±cients, the mRMI value (> 26:5 scores, OR ¼ 10:283) was able to distinguish between the mFAC categorizations (HG and LG) ( Table 5 ). However, MWV (> 0:92 m/s, OR ¼ 22:027) was the most e®ective value for discriminating between LG (mFAC VI) and HG (mFAC ¼ VII). 
Discussion
This study investigated whether the cut-o® values of mRMI and walking velocities can di®erentiate the mFAC scores of stroke patients who were divided into two groups based on the mFAC clas-si¯cation of their functional walking levels. As expected, our results found that there were significant di®erences between HG and LG in the mean AE SD mRMI score (32:33 AE 3:74 and 24: LG (mFAC VI). The MWV and mRMI were more suitable assessments to classify walking function levels than CWV. The cut-o® values of MWV (0.92 m/s, OR ¼ 22:03) had the highest distinguishing power among the assessments evaluated. Additionally, the walking velocities and modi¯ed mRMI scores of patients of di®erent mFAC categories were investigated, with particular focus on the outcomes which showed that MWV could di®erentiate between patients of mFAC IV and those of mFAC V, between patients of mFAC V and those of mFAC VI, and between patients of mFAC VI and those of mFAC VII with robust statistical power. It is noteworthy that the CWV and MWV were signi¯cantly di®erent between mFAC IV and mFAC V, between mFAC V and mFAC VI, and between mFAC VI and mFAC VII. This result showed that walking velocities may be the discriminatory variable for chronic stroke patients belonging to an mFAC higher than IV. However, no variable was signi¯cantly di®erent between mFAC III and mFAC IV. This failure to identify the low mFAC is a consistent limitation in the previous study, 7 which reported the walking velocities of acute stroke patients of mFAC categories ranging from III to IV from di®erent hospitals. The small number of stroke patients included in mFAC III and mFAC IV may account for these results compared to the results observed for patients of other categories. Overall, all variables might not be sensitive to di®erentiate between mFAC III and mFAC IV in the chronic stroke patients.
The rationale for the score of VII as the cut-o® value of the mFAC score is based on the probability of community ambulation without falling. Our categories emphasized reduced ambulation, especially outdoors, as that correlates to a greater factor of debilitation based on a study of 40 people with stroke. 16 Therefore, we decided that the achievement of walking indoors with/without assistance versus walking independently outdoors is the best criteria for de¯ning the overall gait ability (such as climbing stairs, walking on uneven levels, etc., and it was not extended to the social outcome).
Our¯ndings were similar to those of preceding studies. The mean walking velocity within the di®erent mFAC categories was shown to have an increasing trend from mFAC III (0.11 m/s, SD ¼ 0:03) to mFAC IV (0.17 m/s, SD ¼ 0:07), mFAC V (0.30 m/s, SD ¼ 0:13), mFAC VI (0.70 m/s, SD ¼ 0:29), and mFAC VII (0.82 m/s, SD ¼ 0: 19) , in a study of 62 acute stroke patients. In another study 6 which examined the reliability and validity of mFAC, the mRMI score and walking velocities within each mFAC category were reported to be signi¯cantly di®erent. As the mFAC improved from III to V, the average walking velocities (comfortable and maximum) increased from 0.16 m/s and 0.25 m/s in mFAC III to 0.50 m/s and 0.58 m/s in mFAC V, with enhancement of mRMI demonstrating functional mobility. Likewise, this trend was also observed between 0.76 m/s and 0.89 m/s in mFAC VI and between 0.88 m/s and 1.12 m/s in mFAC VII, respectively. 6 Focusing on sensitivity and speci¯city, the mRMI showed a sensitivity of 95%, corresponding to the probability of dividing those with mRMI of > 26:5 among 21 participants in the HG, and a speci¯city of 62%, corresponding to the probability of correctly classifying those with mRMI of 26:5 among 61 participants in the LG. On the other hand, MWV showed higher speci¯city (93%) than mRMI, and CWV showed high accuracy in both sensitivity (90%) and speci¯city (88%). If a stroke survivor has mRMI of > 26:5, CWV of > 0:77 m/s, and MWV of > 0:92 m/s, a physical therapist will consider that the person is able to ambulate outdoors (high walking level), it helps to con¯rm the level of walking function. We considered that only the results of sensitivity and speci¯city were di±cult to determine the implications. However, it has been reported that higher ambulation velocity leads to better mobility, and stroke survivors' ambulation activities are almost unlimited if they can ambulate freely. 10, 13, 17 According to the cases of Tsang et al. 7 of initial stroke patients' hospitalization and discharge, the AUC level of mRMI was identi¯ed similarly (AUC ¼ 0:79), and the cut-o® value of > 20 was slightly inconsistent with the present¯ndings. The mean score (SD) of mRMI was 26.62 (6.2) in chronic stroke patients in this study, and was 20.6 (9.3) at admission in acute stroke patients in Tsang et al.'s 7 prospective study. The inconsistent¯ndings might be explained by the fact that there were di®erences in the post-stroke period of the participants and di®erences in study design. In Tsang et al.'s study, 7 the assessments were performed in hospital settings with assistance and monitoring, without any actual experience of community ambulation. However, our study included outpatient experiences in community ambulation.
Our results of walking velocities are consistent with those of previous studies. An et al. 18 reported that walking velocity (OR ¼ 9:20) was the most powerful determinant variable of community walking among several assessments including the Berg Balance Scale, walking distance, and the Fugl-Meyer assessment. A previous study stated that walking velocity is a strong factor for predicting the level of community walking. 10 In accordance with previous studies, the results of this study suggested that maximum walking velocity (OR ¼ 22:03) is a superior clinical assessment to discriminate between di®erent categories of functional ambulation (HG and LG).
The research¯ndings by Lord et al. 10 suggest that the FAC does not re°ect the real community ambulation levels. However, Hill et al. 19 suggested that to achieve a successful gait within the community, at least FAC ¼ VI, the equivalent of mFAC ¼ VII, is necessary. The use of only mFAC is not su±cient to assure community ambulation ability. The mRMI describes the patient's mobility to perform an activity, 5 and walking velocity (comfortable/maximum) is a valid measure for identifying therapy e®ectiveness in stroke patients. 10 These results support the¯ndings of this study, which suggest the physiotherapist can be better informed of the stroke patients' prognosis for functional walking levels during rehabilitation based on the walking velocity scores compared to mFAC alone.
Study limitations
Despite the clear¯ndings of this study, it has several unavoidable limitations. This study supports the applicability of dichotomized walking velocity and mRMI score in chronic stroke patients. However, the application of walking velocity and mRMI is limited to acute stroke patients. In addition, although the participants were from subsidy-supported rehabilitation hospitals, their functional gait ability varied, and they required assistive tools or support for walking. This requirement may be associated with a fall history, which could lead to a loss of con¯dence to walk actively. 20 Therefore, to advance and validate our results, a study should be conducted in the future reporting on factors pertaining to gait ability and the need to identify a clinical variable that can especially discriminate between patients of mFAC III and those of mFAC IV.
Conclusion
In conclusion, this study demonstrated that the cut-o® values of walking velocity and mRMI are able to discriminate between two groups within mFAC (HG and LG). As these measures of mobility are easy to assess in clinical settings, the dichotomized walking velocity and mRMI are useful for examining the walking ability in a population with chronic stroke. Future research is required to identify the cut-o® values of additional measures of mobility in populations with neurological disorders.
